FindTrial
Sign In

A Clinical-Pathological-Radiological Multimodal Model for Predicting Prognosis in Papillary Renal Cell Carcinoma

A Clinical-Pathological-Radiological Multimodal Model for Predicting Prognosis in Papillary Renal Cell Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120838
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary renal cell carcinoma (pRCC)

Interventions

Retrospective cohort:no
Prospective cohort:no

Sponsors

Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with a confirmed pathological diagnosis of papillary renal cell carcinoma (pRCC). 2.Patients with non-metastatic pRCC who have undergone surgical resection (pathological stage T1-3N0-1M0). 3. Availability of preoperative contrast-enhanced CT images and H&E-stained section

Exclusion criteria

Exclusion criteria: 1. Cases where the tumor type cannot be determined based on histopathological sections. 2.Patients with concurrent primary tumors at other sites. 3. Cases deemed ineligible by the investigator due to other factors.

Design outcomes

Primary

MeasureTime frame
progression free survival(PFS);AUC;accuracy;sensitivity;specificity;—

Secondary

MeasureTime frame
overall survival(OS);—

Countries

China

Contacts

Public ContactZhai Wei

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

jacky_zw2002@hotmail.com+86 187 0177 1959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026